Clinical trial
A Non-Invasive Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy: a Multi-Center, Prospective, Non-Randomized Validation Study
NCT06762704 is registered in ClinicalTrials.gov with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-Invasive Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy: a Multi-Center, Prospective, Non-Randomized Validation Study
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 28, 2025
- Completion date
- December 31, 2027
- Enrollment
- 1,408 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
preimplantation genetic testing (pgt), the focus is to validate the accuracy of a non-invasive artificial intelligence model for the prediction of the human blastocyst ploidy